Potentiation of Δ9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of μ- and κ-opioid receptors

A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS

Litchfield, J. T., & Wilcoxon, F. (1949) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03549-9 · Cited by 7,839 · see citing works

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

A METHOD FOR DETERMINING LOSS OF PAIN SENSATION

D'AMOUR, F. E., & Smith, D. L. (1941) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03823-6 · Cited by 3,238 · see citing works

Intrathecal morphine in mice: A new technique

Hylden, J. L. K., & Wilcox, G. L. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90515-4 · Cited by 1,930 · see citing works

SYNTHETIC ANALGESICS. II. DITHIENYLBUTENYL- AND DITHIENYLBUTYLAMINES

Eddy, N. B., & Leimbach, D. G. (1953) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)05180-8 · Cited by 1,765 · see citing works

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,751 · see citing works

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585 · see citing works

PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE

Haley, T. J., & McCormick, W. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb01354.x · Cited by 1,535 · see citing works

Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry

Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 663 · see citing works

Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.

Takemori, A. E., Ho, B. Y., Naeseth, J. S., & Portoghese, P. S. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21011-4 · Cited by 410 · see citing works

κ-Opioid receptors and analgesia

Millan, M. J. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90321-x · Cited by 324 · see citing works

Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine.

Ward, S. J., Portoghese, P. S., & Takemori, A. E. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32972-1 · Cited by 303 · see citing works

Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.

Welch, S. P., & Stevens, D. L. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10720-9 · Cited by 208 · see citing works

Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.

Smith, P. B., Welch, S. P., & Martin, B. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38633-7 · Cited by 131 · see citing works

Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid δ and dopamine D1 receptor stimulation

Baamonde, A., Daugé, V., Ruiz‐Gayo, M., Fulga, I., Turcaud, S., Fournié‐Zaluski, M., & Roques, B. P. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90356-9 · Cited by 125 · see citing works

Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.

Welch, S. P., Thomas, C., & Patrick, G. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24328-2 · Cited by 124 · see citing works

Bimorphinans as highly selective, potent .kappa. opioid receptor antagonists

Portoghese, P. S., Lipkowski, A. W., & Takemori, A. E. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00385a002 · Cited by 112 · see citing works

Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.

Roerig, S. C., & Fujimoto, J. M. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23495-4 · Cited by 105 · see citing works

Modulation of rat brain opioid receptors by cannabinoids.

VAYSSE, P. J. ‐., Gardner, E. L., & Zukin, R. S. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00276-9 · Cited by 102 · see citing works

Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice

Bhargava, H. N. (1976) · Psychopharmacology · doi:10.1007/bf00426828 · Cited by 79 · see citing works

Inhibition of naloxone-induced withdrawal in morphine dependent mice by l-trans-Δ9-tetrahydrocannabinol

Bhargava, H. N. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90283-1 · Cited by 64 · see citing works

A role for central cannabinoid and opioid systems in peripheral Δ9-tetrahydrocannabinol-induced analgesia in mice

Reche, I., Fuentes, J. A., & Ruiz‐Gayo, M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00045-3 · Cited by 64 · see citing works

9-nor-9beta-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: comparisons with morphine.

Bloom, A. S., Dewey, W. L., Harris, L. S., & Brosius, K. K. (1977) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30767-6 · Cited by 59 · see citing works

Antagonism by chlornaltrexamine of some effects of Δ9-tetrahydrocannabinol in rats

Tulunay, F. C., Ayhan, I. H., Portoghese, P. S., & Takemori, A. E. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90217-x · Cited by 48 · see citing works

Systemic single dose morphine pretreatment desensitizes mice to the spinal antianalgesic action of dynorphin A (1-17).

Fujimoto, J. M., & Holmes, B. B. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12573-1 · Cited by 22 · see citing works

Descending control of pain

Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035 · see citing works

Cannabinoid receptors and pain

Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741 · see citing works

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436 · see citing works

Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial

Portenoy, R. K., Ganae-Motan, E. D., Allende, S., Yanagihara, R., Shaiova, L., Weinstein, S., McQuade, R., Wright, S., & Fallon, M. T. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2012.01.003 · Cited by 420 · see citing works

Pharmacological and biochemical interactions between opioids and cannabinoids

Manzanares, J., Corchero, J., Romero, J., Fernández‐Ruíz, J., Ramos, J. A., & Fuentes, J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01339-5 · Cited by 391 · see citing works

Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities

Pertwee, R. G. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0381 · Cited by 351 · see citing works

Synergistic interactions between cannabinoid and opioid analgesics

Cichewicz, D. L. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.09.038 · Cited by 305 · see citing works

Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse

Cossu, G., Ledent, C. A., Fattore, L., Impérato, A., Böhme, G. A., Parmentier, M., & Fratta, W. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00311-9 · Cited by 272 · see citing works

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis

Nielsen, S., Sabioni, P., Trigo, J. M., Ware, M. A., Betz-Stablein, B. D., Murnion, B., Lintzeris, N., Khor, K. E., Farrell, M., Smith, A., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.51 · Cited by 265 · see citing works

Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid Receptors

Ghozland, S. G., Matthes, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., & Maldonado, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01146.2002 · Cited by 263 · see citing works

An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics

Johnson, J. R., Lossignol, D., Burnell-Nugent, M., & Fallon, M. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.07.014 · Cited by 259 · see citing works

Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice

Martín, M., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00287.x · Cited by 237 · see citing works

Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects

Wallace, M. J., Wiley, J. L., Martin, B. R., & DeLorenzo, R. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01243-2 · Cited by 227 · see citing works

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain

Anand, P., Whiteside, G. T., Fowler, C. J., & Hohmann, A. G. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.003 · Cited by 217 · see citing works

Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …

Baron, E. P. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12570 · Cited by 205 · see citing works

Molecular and cellular basis of cannabinoid and opioid interactions

Viganò, D., Rubino, T., & Parolaro, D. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.021 · Cited by 167 · see citing works

Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System

McPartland, J. M., Guy, G. W., & Marzo, V. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089566 · Cited by 161 · see citing works

CB1-cannabinoid and μ-opioid receptor co-localization on postsynaptic target in the rat dorsal horn

Salio, C., Fischer, J., Franzoni, M. F., Mackie, K., Kaneko, T., & Conrath, M. (2001) · Neuroreport · doi:10.1097/00001756-200112040-00017 · Cited by 159 · see citing works

Antinociceptive Synergy between Δ9-Tetrahydrocannabinol and Opioids after Oral Administration

Cichewicz, D. L., & McCarthy, E. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045575 · Cited by 154 · see citing works

Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of Δ9-tetrahydrocannabinol in rats

Manzanares, J., Corchero, J., & Fuentes, J. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01756-4 · Cited by 152 · see citing works

From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis

Mechoulam, R., & Ben‐Shabat, S. (1999) · Natural Product Reports · doi:10.1039/a703973e · Cited by 139 · see citing works

Cannabinoids modulate pain by multiple mechanisms of action

Richardson, J. D. (2000) · The Journal of Pain · doi:10.1016/s1526-5900(00)90082-8 · Cited by 109 · see citing works

The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice

Shafaroodi, H., Samini, M., Moezi, L., Homayoun, H., Sadeghipour, H., Tavakoli, S., Hajrasouliha, A. R., & Dehpour, A. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.04.011 · Cited by 105 · see citing works

Cannabis-Based Medicines and Pain: A Review of Potential Synergistic and Entourage Effects

Anand, U., Pacchetti, B., Anand, P., & Sodergren, M. H. (2021) · Pain Management · doi:10.2217/pmt-2020-0110 · Cited by 128 · see citing works

Two distinctive antinociceptive systems in rats with pathological pain

Mao, J., Price, D. D., Lü, J., Keniston, L., & Mayer, D. J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00998-2 · Cited by 104 · see citing works

AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies

Seely, K. A., Brents, L. K., Franks, L. N., Rajasekaran, M., Zimmerman, S. M., Fantegrossi, W. E., & Prather, P. L. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.046 · Cited by 103 · see citing works

Analgesic, Respiratory and Heart Rate Effects of Cannabinoid and Opioid Agonists in Rhesus Monkeys: Antagonist Effects of SR 141716A

Vivian, J. A., Kishioka, S., Butelman, E. R., Broadbear, J., Lee, K. O., & Woods, J. H. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37642-6 · Cited by 98 · see citing works

Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies

Nielsen, S., Picco, L., Murnion, B. P., Winters, B. L., Matheson, J., Graham, M., Campbell, G., Parvaresh, L., Khor, K. E., Betz‐Stablein, B., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01322-4 · Cited by 103 · see citing works

A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain

Hoggart, B., Ratcliffe, S. H., Ehler, E., Simpson, K. H., Hovorka, J., Lejčko, J., Taylor, L., Lauder, H., & Serpell, M. G. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7502-9 · Cited by 87 · see citing works

Bivalent Ligands That Target μ Opioid (MOP) and Cannabinoid1 (CB1) Receptors Are Potent Analgesics Devoid of Tolerance

Naour, M. L., Akgün, E., Yekkirala, A. S., Lunzer, M. M., Powers, M. D., Kalyuzhny, A. E., & Portoghese, P. S. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005219 · Cited by 85 · see citing works

Interaction between naltrexone and oral THC in heavy marijuana smokers

Haney, M., Bisaga, A. M., & Foltin, R. W. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1279-8 · Cited by 83 · see citing works

The μ‐opioid receptor agonist morphine, but not agonists at δ‐ or κ‐opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors

Da Fonseca Pacheco, D., Klein, A., De Castro Perez, A., Da Fonseca Pacheco, C. M., De Francischi, J. N., & Duarte, I. D. G. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.175 · Cited by 81 · see citing works

Opioid receptor heteromers in analgesia

Costantino, C. M., Gomes, I., Stockton, S. D., Lim, M. P., & Devi, L. A. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.5 · Cited by 81 · see citing works

Synergy between Δ9-tetrahydrocannabinol and morphine in the arthritic rat

Cox, M. L., Haller, V. L., & Welch, S. P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.010 · Cited by 78 · see citing works

Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain

Finn, D. P., Beckett, S. R. G., Roe, C. H., Madjd, A., Fone, K. C. F., Kendall, D. A., Marsden, C. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03177.x · Cited by 76 · see citing works

Cannabinoids as potential new analgesics

Fuentes, J., Ruiz‐Gayo, M., Manzanares, J., Vela, G., Reche, I., & Corchero, J. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00290-8 · Cited by 72 · see citing works

Interactions between μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists in Rhesus Monkeys: Antinociception, Drug Discrimination, and Drug Self-Administration

Maguire, D. R., Yang, W., & France, C. P. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204099 · Cited by 71 · see citing works

Towards cannabinoid drugs – revisited

Mechoulam, R., Hanus, L. O., & Fride, E. (1998) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70037-7 · Cited by 70 · see citing works

Central antinociception induced by µ‐opioid receptor agonist morphine, but not δ‐ or κ‐, is mediated by cannabinoid CB1receptor

Pacheco, D. D. F., Klein, A., Perez, A. C., Pacheco, C. M. D. F., Francischi, J. N., Reis, G. M. L., & Duarte, I. D. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00310.x · Cited by 68 · see citing works

Time-dependent differences of repeated administration with Δ9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by μ-opioid and CB1-cannabinoid receptors in the caudate–putamen

Corchero, J., Romero, J., Berrendero, F., Fernández‐Ruíz, J., Ramos, J. A., Fuentes, J. A., & Manzanares, J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00053-4 · Cited by 67 · see citing works

Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice

Castañé, A., Robledo, P., Matifas, A., Kieffer, B. L., & Maldonado, R. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02409.x · Cited by 67 · see citing works

Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems

Viganò, D., Rubino, T., Vaccani, A., Bianchessi, S., Marmorato, P., Castiglioni, C., & Parolaro, D. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0114-4 · Cited by 64 · see citing works

Enhancement of μ Opioid Antinociception by Oral Δ9-Tetrahydrocannabinol: Dose-Response Analysis and Receptor Identification

Cichewicz, D. L., Martin, Z. L., Smith, F. L., & Welch, S. P. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38212-6 · Cited by 60 · see citing works

Perinatal Δ9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats

Corchero, J., Garcı́a-Gil, L., Manzanares, J., Fernández‐Ruíz, J., Fuentes, J. A., & Ramos, J. A. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00341-5 · Cited by 46 · see citing works

Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors

Hamann, W., & di Vadi, P. P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05429-4 · Cited by 45 · see citing works

Regional differences in naloxone modulation of Δ9-THC induced Fos expression in rat brain

Allen, K. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00364-7 · Cited by 44 · see citing works

Cannabinoid receptor and WIN 55 212‐2‐stimulated [35S]‐GTPγS binding in the brain of mu‐, delta‐ and kappa‐opioid receptor knockout mice

Berrendero, F., Mendizábal, V. E., Murtra, P., Kieffer, B. L., & Maldonado, R. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02951.x · Cited by 43 · see citing works

Medical Efficacy of Cannabinoids and Marijuana: A Comprehensive Review of the Literature

Bagshaw, S. M., & Hagen, N. A. (2002) · Journal of Palliative Care · doi:10.1177/082585970201800207 · Cited by 43 · see citing works

Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide

Reis, G. M. L., Pacheco, D. F., Perez, A. C., Klein, A., Ramos, M. A., & Duarte, I. D. G. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.06.012 · Cited by 41 · see citing works

Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTPγS binding in morphine-dependent mice

Romero, J., Fernández‐Ruíz, J., Vela, G., Ruiz‐Gayo, M., Fuentes, J. A., & Ramos, J. A. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00036-2 · Cited by 38 · see citing works

Opioid-sparing effects of cannabinoids: Myth or reality?

Foll, B. L. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110065 · Cited by 32 · see citing works

Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by Δ9-tetrahydrocannabinol

Williams, I. J., Edwards, S., Rubo, A., Haller, V. L., Stevens, D. L., & Welch, S. P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.04.003 · Cited by 29 · see citing works

A Novel Role of Cannabinoids: Implication in the Fever Induced by Bacterial Lipopolysaccharide

Benamar, K., Yondorf, M. Z., Meissler, J. J., Geller, E. B., Tallarida, R. J., Eisenstein, T. K., & Adler, M. W. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.113159 · Cited by 29 · see citing works

Repeated administration of Δ9-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat

Corchero, J., Manzanares, J., & Fuentes, J. A. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00195-6 · Cited by 27 · see citing works

Synergistic anti-allodynic effects of nociceptin/orphanin FQ and cannabinoid systems in neuropathic mice

Gündüz, Ö., Karadağ, Ç. H., & Ulugöl, A. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.05.029 · Cited by 25 · see citing works

A Dramatic Response to Inhaled Cannabis in a Woman with Central Thalamic Pain and Dystonia

Chatterjee, A., Almahrezi, Ware, & Fitzcharles (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00426-8 · Cited by 24 · see citing works

Inhibition of opioid-degrading enzymes potentiates Δ9-tetrahydrocannabinol-induced antinociception in mice

Reche, I., Ruiz‐Gayo, M., & Fuentes, J. A. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00005-7 · Cited by 24 · see citing works

Cannabinoid 1 and mu-Opioid Receptor Agonists Synergistically Inhibit Abdominal Pain and Lack Side Effects in Mice

Yu, Y., Tsang, Q. K., Jaramillo-Polanco, J., Lomax, A. E., Vanner, S. J., & Reed, D. E. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0641-22.2022 · Cited by 21 · see citing works

The Medicinal Cannabis Treatment Agreement

Wilsey, B. L., Atkinson, J. H., Marcotte, T. D., & Grant, I. (2014) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000145 · Cited by 20 · see citing works

CB1 receptor knockout mice show similar behavioral modifications to wild-type mice when enkephalin catabolism is inhibited

Jardinaud, F., Crété, D., Canestrelli, C., Ledent, C. A., Roques, B. P., & Noble, F. (2005) · Brain Research · doi:10.1016/j.brainres.2005.09.015 · Cited by 19 · see citing works

Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy

Pota, V., Sansone, P., Sarno, S. D., Aurilio, C., Coppolino, F., Barbarisi, M., Barbato, F., Fiore, M., Cosenza, G., Passavanti, M. B., et al. (2024) · Behavioural Neurology · doi:10.1155/2024/1228194 · Cited by 17 · see citing works

Gender differences in proenkephalin gene expression response to ∆9-tetrahydrocannabinol in the hypothalamus of the rat

Corchero, J., Fuentes, J. A., & Manzanares, J. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600401 · Cited by 17 · see citing works

Analgesic Effects and Impairment in Locomotor Activity Induced by Cannabinoid/Opioid Combinations in Rat Models of Chronic Pain

Alsalem, M., Altarifi, A., Haddad, M., Azab, B., Kalbouneh, H., Imraish, A., Saleh, T., & El‐Salem, K. (2020) · Brain Sciences · doi:10.3390/brainsci10080523 · Cited by 15 · see citing works

Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and ▵9-THC

Araya, K. A., Pessoa-Mahana, C. D., & González, L. G. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.013 · Cited by 14 · see citing works

Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality

Carrascosa, A. J., Navarrete, F., Saldaña, R., García‐Gutiérrez, M. S., Moreno, B. M., Navarro, D., Gómez-Guijarro, F. M., Gasparyan, A., Murcia-Sánchez, E., Torregrosa, A. B., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116268 · Cited by 16 · see citing works

Evidence for the involvement of opioid and cannabinoid systems in the peripheral antinociception mediated by resveratrol

Oliveira, C. D. C., Castor, M. G. M. E., Castor, C. G. M. E., Costa, Á. D. F., Ferreira, R. C. M., da Silva, J. F., Pelaez, J. M. N., Capettini, L. D. S. A., Lemos, V. S., Duarte, I. D. G., et al. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.02.004 · Cited by 13 · see citing works

Neuropeptide VF Enhances Cannabinoid Agonist WIN55,212-2-Induced Antinociception in Mice

Han, Z., Wang, Z., Li, X., Li, N., Pan, J.-X., Zheng, T., Fang, Q., & Wang, R. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000921 · Cited by 13 · see citing works

Involvement of opioid system in cognitive deficits induced by ∆9-tetrahydrocannabinol in rats

Egashira, N., Manome, N., Mishima, K., Iwasaki, K., Oishi, R., & Fujiwara, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2442-x · Cited by 12 · see citing works

N-(4-Methoxy-2-nitrophenyl)hexadecanamide, a palmitoylethanolamide analogue, reduces formalin-induced nociception

Roa‐Coria, J. E., Navarrete‐Vázquez, G., Fowler, C. J., Flores‐Murrieta, F. J., Déciga‐Campos, M., & Granados‐Soto, V. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.09.024 · Cited by 11 · see citing works

Further Characterization of Hemopressin Peptide Fragments in the Opioid and Cannabinoid Systems

Szlávicz, E., Perera, P. S., Tömböly, C., Helyes, Z., Zádor, F., Benyhe, S., Borsodi, A. D., & Bojnik, E. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000964 · Cited by 11 · see citing works

The effect of chronic opioid vs. cannabinoid exposure on the expression of tolerance to morphine- or WIN-55,212-2-induced analgesia and hypothermia in the guinea pig

Maguma, H. T., & TAYLOR, D. A. H. B. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.010 · Cited by 11 · see citing works

Multitarget ligands that comprise opioid/nonopioid pharmacophores for pain management: Current state of the science

Breault, É., Desgagné, M., Neve, J. D., Côté, J., Barlow, T. M. A., Ballet, S., & Sarret, P. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107408 · Cited by 10 · see citing works

The Development of Cannabinoids as Therapeutic Agents in the United States

Murray, C. H., Gannon, B. M., Winsauer, P. J., Cooper, Z. D., & Delatte, M. S. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001121 · Cited by 9 · see citing works

Regulation of δ opioid receptors by Δ9-tetrahydrocannabinol in NG108-15 hybrid cells

Toro, R. D., Campana, G., Sciarretta, V., Murari, G., & Spampinato, S. M. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00390-7 · Cited by 8 · see citing works

Medical Management of Traumatic Neuropathies

Gregg, J. M. (2001) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/s1042-3699(20)30149-7 · Cited by 7 · see citing works

Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture

Morris, T. M., Cucinello‐Ragland, J. A., Marks, T. J., Prevost, K., Glenn, J. F., Davenport, G. J., Edwards, S., & Winsauer, P. J. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173692 · Cited by 5 · see citing works

Opioid System Involvement in Cannabinoid Tolerance and Dependence

Maldonado, R. J. (1882) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_12 · Cited by 5 · see citing works

Estudio de los mecanismos neuronales implicados en las respuestas motivacionales de las drogas de abuso

Sánchez, M., & Miquel (2003) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 3 · see citing works

The Roles of Opioid Receptors and Agonists in Health and Disease Conditions

Ibegbu, A. O., Mullaney, I., Fyfe, L., & MacBean, D. (2011) · Queen Margaret University Publications Repository (Queen Margaret University) · Cited by 1 · see citing works

Cannabinoid targets for pain therapeutics

Huang, S. M., & Walker, J. M. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_8 · Cited by 1 · see citing works

Review on Amygdala Neural Circuitry of Antinociception: On Actions of Opioids and Endocannabinoids

MaengSikShin (2010) · 한국심리학회지: 인지 및 생물 · doi:10.22172/cogbio.2010.22.3.008

Role of Heteromeric GPCR Interactions in Pain/Analgesia

Smith, A. P., & Lee, N. M. (2005) · Contemporary clinical neuroscience · doi:10.1007/978-1-59259-919-6_16

Cannabinoids

Pertwee, R. G. (2003) · CRC Press eBooks · doi:10.1201/9780203911259.ch56

OPIOID-CANNABINOID CODRUGS WITH ENHANCED ANALGESIC AND PHARMACOKINETIC PROFILE

Dhooper, H. K. (2010) · UKnowledge (University of Kentucky) · Cited by 1 · see citing works

Le récepteur opioïde Mu et les interactions entre systèmes opioïde et cannabinoïde dans les effets nociceptifs et addictogènes de la morphine

Roeckel, L.-A. (2018) · doi:10.70675/f064a30ezd18fz44f5za9a5z7fd570a696b8

Cellular and Behavioral Interactions of Cannabinoid and Opioid Systems in Pain, Mood, Reward, and Addiction

Mohammadkhani, A., Peterson, C. S., & Borgland, S. L. (2026) · Springer eBooks · doi:10.1007/978-3-032-12239-1_14

Neurobiología de la drogadicción. Cannabis

Enbeita, G. L., & Méndez, S. V. (2001) · Hedatuz - Repositorio Digital de Euskomedia

The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.

Pugh, G., Smith, P. B., Dombrowski, D. S., & Welch, S. P. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21168-5 · Cited by 123 · see citing works

Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.

Cichewicz, D. L., Martin, Z. L., Smith, F. L., & Welch, S. P. (1999) · PubMed · Cited by 121 · see citing works

The Enhancement of Morphine Antinociception in Mice by Δ9-Tetrahydrocannabinol

Smith, F. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00012-4 · Cited by 146 · see citing works

Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception

Li, J., McMahon, L. R., Gerak, L. R., Becker, G. L., & France, C. P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1157-0 · Cited by 57 · see citing works

Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine

Roberts, J. D., Gennings, C., & Shih, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.11.036 · Cited by 103 · see citing works